{"id":12835,"date":"2022-04-21T09:00:35","date_gmt":"2022-04-21T07:00:35","guid":{"rendered":"https:\/\/iabnetz.de\/?post_type=publikationen&p=12835"},"modified":"2025-11-14T22:38:08","modified_gmt":"2025-11-14T21:38:08","slug":"modified-constraint-induced-movement-therapy-or-bimanual-occupational-therapy-following-injection-of-botulinum-toxin-a-to-improve-bimanual-performance-in-young-children-with-hemiplegic-cerebral-pa-2-4","status":"publish","type":"page","link":"https:\/\/relaunch.iabnetz.com\/en\/publikationen\/weitere-veroeffentlichungen\/modified-constraint-induced-movement-therapy-or-bimanual-occupational-therapy-following-injection-of-botulinum-toxin-a-to-improve-bimanual-performance-in-young-children-with-hemiplegic-cerebral-pa-2-4\/","title":{"rendered":"RESEARCH PAPER Long-term ef\ufb01cacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia: Dressler D et al."},"content":{"rendered":"

<\/p>\n

\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\u00a0J Neurol Neurosurg Psychiatry\u00a0<\/span><\/span>\u00a02013;<\/span>84<\/span>:1014<\/span>\u2013<\/span>1019.
\ndoi:10.1136\/jnnp-2012-303608<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
Authors:<\/span><\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
Dirk Dressler,\u00a0\u00a0<\/span>1<\/span><\/div>\n
Sebastian Paus,\u00a0\u00a0<\/span>2<\/span><\/div>\n
Andrea Seitzinger,\u00a0\u00a0<\/span>3<\/span><\/div>\n
Bernd Gebhardt,\u00a0\u00a0<\/span>3<\/span><\/div>\n
Andreas Kupsch\u00a0\u00a0<\/span>4,5<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\u00a0<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\u00a0<\/a><\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

 <\/p>\n

\n

Author Details:<\/p>\n

\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
1\u00a0\u00a0<\/span>Movement Disorders Section, <\/span>Department of Neurology, <\/span>Hannover Medical School, <\/span>Hannover, Germany<\/span><\/div>\n
2 <\/span>Department of Neurology, <\/span>University of Bonn, Bonn, <\/span>Germany<\/span><\/div>\n
3\u00a0<\/span>Merz Pharmaceuticals GmbH, <\/span>Frankfurt am Main, Germany<\/span><\/div>\n
4 <\/span>Clinic and Policlinic for <\/span>Neurology, Charit\u00e9-<\/span>Universit\u00e4tsmedizin, Berlin, <\/span>Germany<\/span><\/div>\n
5 <\/span>Department of Neurology and <\/span>Stereotactic Neurosurgery, <\/span>University of Magdeburg, <\/span>Germany<\/span><\/div>\n
<\/div>\n
Correspondence\u00a0to<\/span><\/span><\/div>\n
Professor Dirk Dressler, Head <\/span>of Movement Disorders <\/span>Section, Department of\u00a0<\/span>Neurology, Hannover Medical <\/span>School, Hannover 30625, <\/span>Germany; dressler.dirk@mh-<\/span>hannover.de<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n

Please click here!<\/a><\/p>\n<\/div>\n<\/div>\n

<\/p>","protected":false},"excerpt":{"rendered":"

ABSTRACT: Introduction: Previously, controlled trials havedemonstrated the ef\ufb01cacy and tolerability of \ufb01xed dosesof incobotulinumtoxinA (Xeomin, NT 201, botulinumtoxin type A free from complexing proteins) to treat cervical dystonia (CD). …<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":30426,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-full-width.php","meta":{"_acf_changed":false,"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"class_list":["post-12835","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/12835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/comments?post=12835"}],"version-history":[{"count":1,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/12835\/revisions"}],"predecessor-version":[{"id":30679,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/12835\/revisions\/30679"}],"up":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/30426"}],"wp:attachment":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/media?parent=12835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}